(Q79578116)
Statements
Tyrosine kinase mutations of JAK2 are rare events in AML but influence prognosis of patients with CBF-leukemias (English)
Christian Thiede
Gerhard Ehninger
Markus Schaich
DSIL2003 AML study group
scientific article published on 01 January 2007